Generics BulletinApotex and Emcure Pharmaceuticals’ Heritage subsidiary have agreed to pay a combined $49.1m to settle three longstanding US antitrust suits alleging that both companies engaged in “widespread, long-ru
Pink SheetApotex and Emcure Pharmaceuticals ' Heritage subsidiary agreed to pay a combined $49.1m to settle three longstanding US antitrust suits alleging the companies engaged in “widespread, long-running” c
ScripGilead Sciences, Inc. ’s voluntary licensing (VL) agreements for lenacapavir may have managed to take some of the sting out of the patent opposition case in India but health groups and activists don’t
Generics BulletinGilead Sciences, Inc. ’s voluntary licensing (VL) agreements for lenacapavir may have managed to take some of the sting out of the patent opposition case in India but health groups and activists don’t